NY Medicaid Recipients To Move Into Managed Care?

1 September 1996

In a 50-page document, the US Health Care Financing Administration has announced the terms under which it will approve a plan allowing New York State to move almost all its 3.5 million Medicaid recipients into managed care. The plan would require all people receiving Medicaid not in nursing homes to get their health care through health maintenance organizations, both to offer improved care and to cut the cost of the $24 million annual program. About half the cost falls to the state.

Among the conditions set out by the federal government are slowing the pace at which the poor are shifted into managed care and making sure plans are prepared to enroll those with serious illnesses such as AIDS. Calling the terms generally acceptable, state officials are now in negotiations on the final terms for the program.

Barbara DeBuono, State Health Commissioner, has said that an agreement was expected within four-to-six weeks, and that she felt that the plan would be in place by the end of the year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight